Clinical Trial Update: A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating HDM1005 for adults with Type 2 diabetes mellitus not controlled by diet and exercise is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HDM1005

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: RECRUITING